Zimmer Biomet Holdings Inc (ZBH) : Anchor Capital Advisors reduced its stake in Zimmer Biomet Holdings Inc by 2.96% during the most recent quarter end. The investment management company now holds a total of 700,868 shares of Zimmer Biomet Holdings Inc which is valued at $91,414,213 after selling 21,348 shares in Zimmer Biomet Holdings Inc , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.Zimmer Biomet Holdings Inc makes up approximately 2.35% of Anchor Capital Advisors’s portfolio.
Other Hedge Funds, Including , Btc Capital Management sold out all of its stake in ZBH during the most recent quarter. The investment firm sold 17,051 shares of ZBH which is valued $2,223,962.Eqis Capital Management boosted its stake in ZBH in the latest quarter, The investment management firm added 1,181 additional shares and now holds a total of 11,216 shares of Zimmer Biomet Holdings Inc which is valued at $1,399,981. Zimmer Biomet Holdings Inc makes up approx 0.09% of Eqis Capital Management’s portfolio.
Zimmer Biomet Holdings Inc opened for trading at $130.62 and hit $131.08 on the upside on Thursday, eventually ending the session at $130.91, with a gain of 0.37% or 0.48 points. The heightened volatility saw the trading volume jump to 9,69,225 shares. Company has a market cap of $26,082 M.
On the company’s financial health, Zimmer Biomet Holdings Inc reported $2.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $1.97. The company had revenue of $1934.00 million for the quarter, compared to analysts expectations of $1898.18 million. The company’s revenue was up 65.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.58 EPS.
Many Wall Street Analysts have commented on Zimmer Biomet Holdings Inc. Company shares were Reiterated by Needham on Jul 29, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $143 .Company shares were Reiterated by Needham on Jul 18, 2016 to “Buy”, Firm has raised the Price Target to $ 143 from a previous price target of $134 .Zimmer Biomet Holdings Inc was Initiated by Guggenheim to “Neutral” on Jun 9, 2016.
Zimmer Biomet Holdings Inc. formerly Zimmer Holdings Inc. is a musculoskeletal healthcare company. The Company designs manufactures and markets orthopedic reconstructive products; sports medicine biologics extremities and trauma products; spine bone healing craniomaxillofacial and thoracic products; dental implants and related surgical products. The Company manages its operations through three geographic segments: the Americas comprising principally of the United States and includes other North Central and South American markets; Europe comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories.